
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for MET and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MET and 80,000+ other tickers.
See exactly how MET's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MET and 80,000+ other tickers.
MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also…

Boston Common Asset Management LLC trimmed its position in MetLife, Inc. (NYSE: MET) by 11.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 109,516 shares of the financial services provider's stock after selling 13,810 shares during the

California Public Employees Retirement System boosted its position in MetLife, Inc. (NYSE: MET) by 2.4% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,063,550 shares of the financial services provider's stock after purchasing an additional 24,552 shares during the

MET is embedding AI across underwriting, claims and service to boost efficiency, improve customer experiences and strengthen long-term competitiveness.

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) will release its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market closes. The earnings news release, financial supplement and related materials will be posted on MetLife's Investor Relations webpage at investor.metlife.com. MetLife will hold its second quarter 2026 earnings conference call on Thursday, August 6, 2026, from 9-10 a.m. (ET) via a live webcast. Please click on the following link to register: ht.

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a third quarter 2026 common stock dividend of $0.5925 per share. The dividend will be payable on September 8, 2026, to shareholders of record as of August 4, 2026. About MetLife MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management.